Lombard Odier Asset Management (USA)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-786
Closed -$381K – 419
2025
Q3
$381K Buy
+786
New +$366K 0.03% 325
2024
Q3
– Sell
-1,068
Closed -$591K – 355
2024
Q2
$591K Buy
+1,068
New +$612K 0.04% 152
2023
Q3
– Sell
-700
Closed -$365K – 435
2023
Q2
$365K Buy
+700
New +$378K 0.01% 279
2018
Q4
– Sell
-10,000
Closed -$2.44M – 270
2018
Q3
$2.44M Buy
+10,000
New +$2.3M 0.18% 146
2017
Q2
– Sell
-10,000
Closed -$1.54M – 279
2017
Q1
$1.54M Buy
+10,000
New +$1.53M 0.14% 147

Other funds holding TMO

Lombard Odier Asset Management (USA)'s TMO Position: Q4 2025 in Review

Lombard Odier Asset Management (USA) sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 786 shares — an estimated $381K sold.

Lombard Odier Asset Management (USA) first reported a position in TMO in Q1 2017 and held it in 5 quarters. The position peaked at $2.44M in Q3 2018. 2,707 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Lombard Odier Asset Management (USA) reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 786 Thermo Fisher Scientific shares in Q4 2025, an estimated $381K.
  • Lombard Odier Asset Management (USA) first reported a position in Thermo Fisher Scientific in Q1 2017 and held it in 5 quarters.
  • Lombard Odier Asset Management (USA)'s Thermo Fisher Scientific position peaked at $2.44M in Q3 2018.
  • 2,707 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2025, filed 17 Feb 2026.